Cellaria, Inc. Introduces A New Generation Of Cell Line Models For Pancreatic Cancer Paving The Way For Better Treatment

WAKEFIELD, Mass.--(BUSINESS WIRE)-- #cellbiology--Cellaria, Inc. (Wakefield, MA, USA), a scientific innovator with breakthrough tools for cancer research, has introduced three next generation Pancreatic Cancer cell lines, substantially boosting the value of in vitro methods in the development of more effective therapies. Difficult to detect and with a poor survival rate, Pancreatic Cancer remains a primary and illusive therapeutic target for researchers. The new cell models are scalable and stable, securely l

Click to view original post